ClinConnect ClinConnect Logo
Search / Trial NCT04899947

Child and Adolescent Registry for Participants With Narcolepsy

Launched by JAZZ PHARMACEUTICALS · May 21, 2021

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

The CATNAP trial is a study that aims to learn more about narcolepsy in children and teenagers. Narcolepsy is a condition that affects sleep, causing excessive daytime sleepiness and sudden sleep attacks. This registry will collect information to help researchers understand how narcolepsy affects young people over time. The study is open to any child or adolescent under 18 years old who has been diagnosed with narcolepsy by a doctor. Participants will need to be comfortable completing the necessary consent forms and participating in English.

If you or someone you know meets these criteria, you can expect to be part of a larger effort to gather important information about narcolepsy in young patients. The study is currently recruiting participants from 16 active clinical sites and also offers a virtual option, making it easier for people across the United States to join. For more details or to enroll, you can visit the CATNAP website or reach out via email. This is a great opportunity to contribute to research that may improve the understanding and treatment of narcolepsy in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
  • Age less than 18 years
  • Willing to participate in the Registry and complete the informed consent form
  • Able to participate in English based registry
  • Exclusion Criteria:
  • Age 18 years or more
  • Fail to complete the informed consent form

About Jazz Pharmaceuticals

Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to identifying, developing, and commercializing innovative therapies that address unmet medical needs in various therapeutic areas, including sleep disorders, neurology, and hematology. With a strong commitment to advancing patient care, Jazz Pharmaceuticals leverages cutting-edge research and development to deliver transformative medicines that improve the quality of life for patients. The company emphasizes collaboration and integrity in its clinical trials, striving to ensure robust scientific rigor and ethical standards throughout its research endeavors. Through its innovative approaches and patient-centric focus, Jazz Pharmaceuticals aims to make a meaningful impact in the lives of those it serves.

Locations

Rochester, Minnesota, United States

Tampa, Florida, United States

Philadelphia, Pennsylvania, United States

Baltimore, Maryland, United States

Kansas City, Missouri, United States

Norfolk, Virginia, United States

Phoenix, Arizona, United States

Cincinnati, Ohio, United States

Washington, District Of Columbia, United States

Tucson, Arizona, United States

Columbus, Ohio, United States

Tampa, Florida, United States

Chesterfield, Missouri, United States

Boston, Massachusetts, United States

Tampa, Florida, United States

Dublin, Ohio, United States

Houston, Texas, United States

San Diego, California, United States

Fayetteville, Arkansas, United States

Tucson, Arizona, United States

Chicago, Illinois, United States

Washington, District Of Columbia, United States

Danville, Pennsylvania, United States

Redwood City, California, United States

Manhasset, New York, United States

Little Rock, Arkansas, United States

Grand Rapids, Michigan, United States

Cleveland, Ohio, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials